Watchlist
New life for a well proven product
− Highly effective product with a vast addressable market
− Reinvigorated strategy and new (proven) management
− Credible plan for high growth path to profitability
Valuation A$3.28
Current price A$0.92
Market cap A$79m
Cash on hand A$24.7m (end FY23)
Upcoming Catalysts and Newsflow
Period
FY24e Next Generation Penthrox inhaler launch
FY24? Potential US partner for Penthrox announce
Another Positive Study, page-147
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
-0.010(2.22%) |
Mkt cap ! $49.56M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 46.0¢ | 44.0¢ | $61.85K | 139.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10442 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 313 | 2 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| MVP (ASX) Chart |